Cytosolix

Curated by Signal

Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors

Overview

Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors. It provides the tumor-activated permeability (TAP) System, which creates weakly acidic derivatives of well-known oncology medications that boost uptake by cancer cells while limiting uptake by healthy cells.

Key facts

Founded: 2017
Headquarters: Tolland, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Optiosurgical
Platform to optimise orthopaedic surgeons in OR
Health TechnologyLakewood, United States
BonfireDW
Digital wellness platform offering online coaching and personalized support for adolescents
Health TechnologyAkron, United States
Pivotal Health Tech
Provider of wearable devices for monitoring seniors
Health TechnologyUnited States

About Cytosolix

What does Cytosolix do?

Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors.

Where is Cytosolix headquartered?

Cytosolix is headquartered in Tolland, United States.

When was Cytosolix founded?

Cytosolix was founded in 2017.

Which sector is Cytosolix in?

Cytosolix operates in Health Technology.

Who are Cytosolix's competitors?

Companies similar to Cytosolix include Optiosurgical, BonfireDW, and Pivotal Health Tech.